We are live on ! Find out more
GAM

Groupama Asset Management Portfolio holdings

AUM $6.85B
1-Year Est. Return 43.37%
This Fund
S&P 500
This Quarter Est. Return
+2.52%
1 Year Est. Return
+43.37%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.37B
AUM Growth
+$1.88B
Cap. Flow
+$1.18B
Cap. Flow %
15.98%
Top 10 Hldgs %
44.46%
Holding
545
New
39
Increased
252
Reduced
81
Closed
100

Top Sells

Rank Stock Value
1
ASML icon
ASML
ASML
+$266M
2
PH icon
Parker-Hannifin
PH
+$67.9M
3
SAN icon
Banco Santander
SAN
+$55.2M
4
KR icon
Kroger
KR
+$15.5M
5
STLA icon
Stellantis
STLA
+$9.81M

Sector Composition

Rank Sector Weight
1 Technology 26.99%
2 Financials 21.18%
3 Healthcare 16.03%
4 Consumer Discretionary 15.24%
5 Communication Services 4.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCI icon
301
Crown Castle
CCI
$33.4B
$806K 0.01%
8,248
+3,203
+63% +$315K
MLM icon
302
Martin Marietta Materials
MLM
$32.4B
$790K 0.01%
+1,458
New +$847K
KMB icon
303
Kimberly-Clark
KMB
$36.6B
$789K 0.01%
11,352
+8,511
+300% +$1.14M
A icon
304
Agilent Technologies
A
$39.2B
$787K 0.01%
6,073
-1,491
-20% -$209K
EXC icon
305
Exelon
EXC
$46.6B
$786K 0.01%
22,696
+12,906
+132% +$476K
GEHC icon
306
GE HealthCare
GEHC
$31.6B
$777K 0.01%
9,970
+3,591
+56% +$293K
ADM icon
307
Archer Daniels Midland
ADM
$38.9B
$777K 0.01%
12,846
+6,119
+91% +$375K
MOS icon
308
The Mosaic Company
MOS
$7.24B
$775K 0.01%
26,808
+18,829
+236% +$567K
DFS
309
DELISTED
Discover Financial Services
DFS
$759K 0.01%
5,800
+311
+6% +$38.8K
GRMN
310
Garmin
GRMN
$57.4B
$749K 0.01%
6,112
+1,566
+34% +$247K
HWM icon
311
Howmet Aerospace
HWM
$111B
$729K 0.01%
+9,385
New +$711K
BLDR icon
312
Builders FirstSource
BLDR
$7.1B
$726K 0.01%
+5,242
New +$890K
HIG icon
313
Hartford Financial Services
HIG
$39.2B
$716K 0.01%
+14,188
New +$1.42M
BSY icon
314
Bentley Systems
BSY
$10.7B
$711K 0.01%
14,397
APH icon
315
Amphenol
APH
$197B
$709K 0.01%
21,032
+4,108
+24% +$259K
PCAR icon
316
PACCAR
PCAR
$70.4B
$703K 0.01%
+6,832
New +$753K
JAZZ icon
317
Jazz Pharmaceuticals
JAZZ
$16.2B
$692K 0.01%
6,485
-1,217
-16% -$134K
PODD icon
318
Insulet
PODD
$11.5B
$687K 0.01%
3,405
+2,856
+520% +$515K
D icon
319
Dominion Energy
D
$61.3B
$679K 0.01%
13,851
+11,745
+558% +$598K
RMD icon
320
ResMed
RMD
$30.3B
$669K 0.01%
3,497
-1,748
-33% -$355K
PET
321
DELISTED
Wag!
PET
$669K 0.01%
+4,231
New +$8.01K
VLTO icon
322
Veralto
VLTO
$23.1B
$662K 0.01%
13,856
+9,836
+245% +$941K
CARR icon
323
Carrier Global
CARR
$50.6B
$659K 0.01%
20,846
+10,423
+100% +$640K
STT icon
324
State Street
STT
$50.2B
$647K 0.01%
8,747
+3,571
+69% +$266K
VRSK icon
325
Verisk Analytics
VRSK
$26.1B
$634K 0.01%
3,825
+1,298
+51% +$318K

Similar funds

Groupama Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Groupama Asset Management held 545 positions worth $7.37B, up 34% from $5.49B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Groupama Asset Management deployed $1.18B of net new capital in Q2 2024, opening 39 new positions and adding to 252 existing holdings. Its largest new stake was ENI: 1,658,471 shares worth $26.1M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Parker-Hannifin, an estimated $67.9M trimmed.

  • Groupama Asset Management's largest Q2 2024 buy was ENI: 1,658,471 shares worth $26.1M.
  • Groupama Asset Management added most to Alphabet (Google) Class A in Q2 2024, an estimated $122M increase.
  • Groupama Asset Management's biggest Q2 2024 reduction was Parker-Hannifin, cutting an estimated $67.9M.
  • Groupama Asset Management fully exited ASML in Q2 2024, selling an estimated $266M.
  • Groupama Asset Management's ten largest holdings make up 44% of its $7.37B portfolio in Q2 2024.
  • Groupama Asset Management opened 39 new positions and closed 100 in Q2 2024.
  • Groupama Asset Management's portfolio value rose 34% quarter-over-quarter to $7.37B.

Based on Groupama Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.